1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
Not Everyone Loses Weight on OzempicNot all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.
1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
Not Everyone Loses Weight on OzempicNot all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.
Weight-loss drug shortages have patients stressed over missing dosesPatients struggle to access anti-obesity medications due to shortages, impacting progress and causing anxiety.
Confessions of an Ozempic-TakerThe chronicler of addictions, Johann Hari, shares his own struggle with willpower and shame.